- Home
- WBA vs JAZZ Comparison
WBA vs JAZZ Comparison
Compare WBA & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WBA
- JAZZ
- Stock Information
- Founded
- WBA 1901
- JAZZ 2003
- Country
- WBA United States
- JAZZ Ireland
- Employees
- WBA N/A
- JAZZ N/A
- Industry
- WBA Retail-Drug Stores and Proprietary Stores
- JAZZ Biotechnology: Pharmaceutical Preparations
- Sector
- WBA Consumer Staples
- JAZZ Health Care
- Exchange
- WBA Nasdaq
- JAZZ Nasdaq
- Market Cap
- WBA 9.4B
- JAZZ 8.4B
- IPO Year
- WBA N/A
- JAZZ 2007
- Fundamental
- Price
- WBA $11.06
- JAZZ $120.82
- Analyst Decision
- WBA Hold
- JAZZ Strong Buy
- Analyst Count
- WBA 12
- JAZZ 13
- Target Price
- WBA $10.59
- JAZZ $187.15
- AVG Volume (30 Days)
- WBA 20.9M
- JAZZ 1.3M
- Earning Date
- WBA 04-08-2025
- JAZZ 04-30-2025
- Dividend Yield
- WBA N/A
- JAZZ N/A
- EPS Growth
- WBA N/A
- JAZZ 41.75
- EPS
- WBA N/A
- JAZZ 8.65
- Revenue
- WBA $150,410,000,000.00
- JAZZ $4,068,950,000.00
- Revenue This Year
- WBA $3.72
- JAZZ $7.55
- Revenue Next Year
- WBA $2.10
- JAZZ $3.52
- P/E Ratio
- WBA N/A
- JAZZ $14.06
- Revenue Growth
- WBA 5.62
- JAZZ 6.12
- 52 Week Low
- WBA $8.08
- JAZZ $99.06
- 52 Week High
- WBA $19.48
- JAZZ $148.06
- Technical
- Relative Strength Index (RSI)
- WBA 50.80
- JAZZ 33.30
- Support Level
- WBA $11.09
- JAZZ $120.61
- Resistance Level
- WBA $11.22
- JAZZ $127.87
- Average True Range (ATR)
- WBA 0.09
- JAZZ 4.27
- MACD
- WBA -0.03
- JAZZ -2.00
- Stochastic Oscillator
- WBA 34.29
- JAZZ 4.55
About WBA Walgreens Boots Alliance Inc.
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.